Introducing Medisca Nutraceuticals

Download in electronic PDF format for $25



Search the Complete Journal Archives

Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program

Author(s):  Okeke Claudia C, Allen Loyd V Jr

Issue:  Jul/Aug 2010 - Sterile Compounding
View All Articles in Issue

Abstract:  This article is intended to address the activities of the caregiver and encourage the need to address adverse events or medical errors. The advantage of disclosing adverse events or medication errors is to avoid further potential errors and determine/correct the cause of the errors. There should be awareness between patients and caregivers on the proper use and administration of intended compounded sterile preparations. Patients/patient’s relatives should ask questions about their medications and be knowledgeable or cognizant on the appearance of the preparation or specified dosage of the medication. Caregivers should be open and explicit about the medications being administered or prescribed by the doctor and the rationale for such medications. This module will address these sections in a practical manner and provide practice clarification to the standards.

Related Keywords: Loyd V. Allen Jr., PhD, RPh, United States Pharmacopeia, USP Chapter <797> Pharmaceutical Compounding -- Sterile Preparations, Claudia C. Okeke, PhD, RPh, quality assurance, patient education, patient monitoring, adverse event reporting, drug errors

Related Categories: STERILE PREPARATIONS, QUALITY CONTROL, PATIENT EDUCATION, UNITED STATES PHARMACOPEIA CONVENTIONS, ADVERSE DRUG EVENTS

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program Okeke Claudia C, Allen Loyd V Jr Jul/Aug 2010 328-331 Buy
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels Allen Loyd V Jr, Okeke Claudia C Sep/Oct 2007 404-410 Buy
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797> Allen Loyd V Jr, Okeke Claudia C Mar/Apr 2008 136-144 Buy
Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations Okeke Claudia C Jul/Aug 2007 302-305 Buy
Basics of Compounding: The Responsibilities of Compounding Personnel in Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 2 Allen Loyd V Jr, Okeke Claudia C Jul/Aug 2007 314-323 Buy
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 9: Immediate-Use Compounded Sterile Preparations Allen Loyd V Jr, Okeke Claudia C Sep/Oct 2008 440-443 Buy
Basics of Compounding: United States Pharmacopeia General Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 10: First Revision: The Main Changes, Events, and Rationale Okeke Claudia C, Newton David W, Kastango Eric S, Allen Loyd V Jr Nov/Dec 2008 530-536 Buy
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 13: Environmental Quality and Control Allen Loyd V Jr, Okeke Claudia C May/Jun 2009 234-238 Buy
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 14: Environmental Quality and Control (Continued) Okeke Claudia C, Allen Loyd V Jr Jul/Aug 2009 322-329 Buy
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs Allen Loyd V Jr, Okeke Claudia C Jan/Feb 2009 56-62 Buy